Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register

B. Keselman, C. Cooray, G. Vanhooren, P. Bassi, D. Consoli, P. Nichelli, A. Peeters, D. Sanak, A. Zini, N. Wahlgren, N. Ahmed, MV. Mazya,

. 2019 ; 26 (8) : 1091-1097. [pub] 20190325

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025737

BACKGROUND AND PURPOSE: Patients with stroke mimics (SM), i.e. conditions with stroke-like symptoms, may risk harm if treated with intravenous thrombolysis (IVT). Current guidelines state low risk of intracerebral hemorrhage based on studies comprising a total of <400 SM cases. We aimed to compare safety and outcomes following IVT between patients with acute ischaemic stroke and mimicking conditions. METHODS: We included IVT-treated ischaemic stroke patients in the SITS International Stroke Thrombolysis Register 2003-2017, examined with magnetic resonance imaging 22-36 h after treatment. Outcomes were parenchymal hematoma (PH) after treatment, symptomatic intracerebral hemorrhage (SICH) per Safe Implementation of Thrombolysis in Stroke Monitoring Study (SITS-MOST), Second European Co-operative Stroke Study (ECASS II) and National Institutes of Neurological Disorders and Stroke Study (NINDS) criteria, death and modified Rankin Scale score (mRS) at 3 months. RESULTS: Of 10 436 patients, 429 mimics (4.1%) were identified. The most common types were functional (30.8%), migraine (17.5%) and seizure (14.2%). Patients with mimics had fewer cerebrovascular risk factors and lower median National Institutes of Health Stroke Scale score [7 (interquartile range, 5-10) vs. 8 (5-14), P < 0.001]. Among mimics versus stroke patients, PH was seen in 1.2% vs. 5.1% (P < 0.001), SICH NINDS in 0.5% vs. 3.9% (P < 0.001), SICH ECASS II in 0.2% vs. 2.1% (P = 0.007) and SICH SITS-MOST in 0% vs. 0.5% (P = 0.28). Modified Rankin Scale score 0-1 at 3 months was present in 84.1% vs. 57.7% (P < 0.001) and death within 3 months in 2.6% vs. 5.4% (P = 0.028) of mimics and stroke patients, respectively. CONCLUSIONS: This large observational study indicated that PH and SICH following IVT in patients with SM are uncommon.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025737
003      
CZ-PrNML
005      
20201222154051.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ene.13944 $2 doi
035    __
$a (PubMed)30793434
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Keselman, B $u Department of Neurology, Karolinska University Hospital and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
245    10
$a Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register / $c B. Keselman, C. Cooray, G. Vanhooren, P. Bassi, D. Consoli, P. Nichelli, A. Peeters, D. Sanak, A. Zini, N. Wahlgren, N. Ahmed, MV. Mazya,
520    9_
$a BACKGROUND AND PURPOSE: Patients with stroke mimics (SM), i.e. conditions with stroke-like symptoms, may risk harm if treated with intravenous thrombolysis (IVT). Current guidelines state low risk of intracerebral hemorrhage based on studies comprising a total of <400 SM cases. We aimed to compare safety and outcomes following IVT between patients with acute ischaemic stroke and mimicking conditions. METHODS: We included IVT-treated ischaemic stroke patients in the SITS International Stroke Thrombolysis Register 2003-2017, examined with magnetic resonance imaging 22-36 h after treatment. Outcomes were parenchymal hematoma (PH) after treatment, symptomatic intracerebral hemorrhage (SICH) per Safe Implementation of Thrombolysis in Stroke Monitoring Study (SITS-MOST), Second European Co-operative Stroke Study (ECASS II) and National Institutes of Neurological Disorders and Stroke Study (NINDS) criteria, death and modified Rankin Scale score (mRS) at 3 months. RESULTS: Of 10 436 patients, 429 mimics (4.1%) were identified. The most common types were functional (30.8%), migraine (17.5%) and seizure (14.2%). Patients with mimics had fewer cerebrovascular risk factors and lower median National Institutes of Health Stroke Scale score [7 (interquartile range, 5-10) vs. 8 (5-14), P < 0.001]. Among mimics versus stroke patients, PH was seen in 1.2% vs. 5.1% (P < 0.001), SICH NINDS in 0.5% vs. 3.9% (P < 0.001), SICH ECASS II in 0.2% vs. 2.1% (P = 0.007) and SICH SITS-MOST in 0% vs. 0.5% (P = 0.28). Modified Rankin Scale score 0-1 at 3 months was present in 84.1% vs. 57.7% (P < 0.001) and death within 3 months in 2.6% vs. 5.4% (P = 0.028) of mimics and stroke patients, respectively. CONCLUSIONS: This large observational study indicated that PH and SICH following IVT in patients with SM are uncommon.
650    _2
$a intravenózní podání $7 D061605
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a ischemie mozku $x diagnóza $x farmakoterapie $7 D002545
650    _2
$a cerebrální krvácení $x chemicky indukované $7 D002543
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a chybná diagnóza $7 D003951
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibrinolytika $x aplikace a dávkování $x škodlivé účinky $x terapeutické užití $7 D005343
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a migréna $x diagnóza $7 D008881
650    _2
$a rizikové faktory $7 D012307
650    _2
$a záchvaty $x diagnóza $7 D012640
650    _2
$a cévní mozková příhoda $x diagnóza $x farmakoterapie $7 D020521
650    _2
$a trombolytická terapie $x škodlivé účinky $7 D015912
650    _2
$a tkáňový aktivátor plazminogenu $x aplikace a dávkování $x škodlivé účinky $x terapeutické užití $7 D010959
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Cooray, C $u Department of Neurology, Karolinska University Hospital and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Vanhooren, G $u Department of Neurology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium.
700    1_
$a Bassi, P $u Neurological Department, San Giuseppe Hospital, Milan.
700    1_
$a Consoli, D $u Department of Neurology, Iazzolino Hospital, Vibo Valentia.
700    1_
$a Nichelli, P $u Stroke Unit Neurology Clinic, Department of Neuroscience, Ospedale Civile S. Agostino Estense, Modena University Hospital, University of Modena and Reggio Emilia, Modena, Italy.
700    1_
$a Peeters, A $u Department of Neurology, Cliniques Universitaires St-Luc, Brussels, Belgium.
700    1_
$a Sanak, D $u Comprehensive Stroke Centre, Department of Neurology, Palacký University Hospital, Olomouc, Czech Republic.
700    1_
$a Zini, A $u Stroke Unit Neurology Clinic, Department of Neuroscience, Ospedale Civile S. Agostino Estense, Modena University Hospital, University of Modena and Reggio Emilia, Modena, Italy.
700    1_
$a Wahlgren, N $u Department of Neurology, Karolinska University Hospital and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Ahmed, N $u Department of Neurology, Karolinska University Hospital and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Mazya, M V $u Department of Neurology, Karolinska University Hospital and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
773    0_
$w MED00001629 $t European journal of neurology $x 1468-1331 $g Roč. 26, č. 8 (2019), s. 1091-1097
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30793434 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222154046 $b ABA008
999    __
$a ok $b bmc $g 1599882 $s 1116423
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 26 $c 8 $d 1091-1097 $e 20190325 $i 1468-1331 $m European journal of neurology $n Eur J Neurol $x MED00001629
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace